ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,725, issued on Oct. 28, was assigned to Celleron Therapeutics Ltd. (Oxford, Great Britain).
"Treatment of inflammatory disease" was invented by Simon Cook (Oxford, Great Britain), David Kerr (Oxford, Great Britain) and Nicholas La Thangue (Oxford, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin-4-yl)benzamide (CXD101), or a pharmaceutically acceptable salt thereof, for use as an anti-inflammatory agent, in particular for use in the treatment of immune checkpoint inhibitor-induced colitis."
The patent was filed on Sept. 25, 2020, unde...